Nidec Sankyo Completes Acquisition of Mitsubishi Materials

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2018
Nidec Sankyo Completes Acquisition of Mitsubishi Materials C.M.I. Corporation and Announces Outline of Its New Subsidiaries

KYOTO, Japan, Jan. 6, 2014 (GLOBE NEWSWIRE) -- Nidec Corporation (NYSE: NJ ) today announced that one of its wholly owned subsidiaries, Nidec Sankyo Corporation ("Nidec Sankyo"), completed the acquisition of Mitsubishi Materials C.M.I. Corporation ("CMI") from Mitsubishi Materials Corporation on January 1, 2014 (the "Transaction").

As a result of the Transaction, CMI became a wholly owned subsidiary of Nidec Sankyo, as outlined below:

1. O utline of New Subsidiaries

A. Company Names  
  Japan: NIDEC SANKYO CMI CORPORATION
  Japan: Sunseiki Co., Ltd.
  Indonesia: PT. HIGASHIFUJI INDONESIA
  Malaysia: HIGASHIFUJI (MALAYSIA) SDN. BHD
  China: Higashifuji Shanghai Co., Ltd.
     
B. Outline of NIDEC SANKYO CMI  
     
  (1) Headquarters: 46-1 Senpuku, Susono City, Shizuoka, Japan
     
  (2) Directors and Officers:  
  Representative Director and Chairman of the Board of Directors (non-executive): Kazuyoshi Yasukawa
    (Representative Director and President of Nidec Sankyo)
  Representative Director and President: Noboru Yonezawa
  Senior Vice President: Eiji Imai (Advisor to Nidec Sankyo)
  Senior Vice President: Masataka Mitsuda
  Senior Vice President: Junichi Hinuma
  Director: Satoru Suzuki
  Director (non-executive): Kazutake Akiba
    (Director and Senior Vice President of Nidec Sankyo)
  Corporate Auditor: Haruki Yuyama
  Corporate Auditor (part-time): Toshinori Uehara
    (Corporate Auditor of Nidec Sankyo)
     
  (3) Principal Locations of Operation: Shizuoka Prefecture (Japan), Toyama Prefecture (Japan), Indonesia, Malaysia, and China
     
  (4) Principal Businesses: Development, manufacturing and sale of small motors, electric contact products and other products
     
  (5) Employees: 1,522 (consolidated);
    342 (non-consolidated) 
    (as of November 30, 2013)

2.  Future Operation Policy

CMI engages primarily in motor and electric contact product businesses.

CMI's motor business primarily focuses on medium-diameter stepping motors particularly for the automotive and other products markets, and CMI has established a competitive market position. On the other hand, with its own high capacity production manufacturing facilities, Nidec Sankyo has established its current competitive position in the motor market by specializing in small-diameter stepping motors for optical disk drives, digital cameras, and other products. Since CMI's product lines do not have much overlap with Nidec Sankyo's product lines, the Transaction is expected to result in enhancement of Nidec Sankyo's product line-up. In addition, the efficient use of managerial and operational resources of Nidec Sankyo and CMI is expected to result in efficient development of new products and improvement in cost competitiveness for both companies with respect to their respective motor businesses. At the same time, CMI's motor products, which have been sold mostly to Japanese customers, can be offered to new markets on a global basis through the Nidec Group's marketing channels in an effort to increase sales.

With respect to the electric contact product business, CMI is particularly strong in the market for on-vehicle relay products. CMI owns manufacturing facilities in China where global automotive relay manufacturers are concentrated. By taking advantage of this geographic advantage, the electric contact business is expected to grow as the global market expands, particularly in the Chinese market. As a result, the electric contact business is expected to significantly contribute to the Nidec Group's growth strategy relating to its automotive motor business.

3 . Effect on Financial Performance for the Current Fiscal Year

Nidec Corporation intends to make appropriate disclosure of the impact of the Transaction described herein on its consolidated financial performance for the current fiscal year and announce any changes to its financial performance forecasts in accordance with the applicable stock exchange rules once such details are determined.

Cautionary Statement Concerning Forward-Looking Information

This press release contains forward-looking statements regarding the intent, belief, strategy, plans or expectations of the Nidec Group or other parties. Such forward-looking statements are not guarantees of future performance or events and involve risks and uncertainties. Actual results may differ materially from those described in such forward-looking statements as a result of various factors, including, but not limited to, the risks to successfully integrating the acquired business with the Nidec Group, the anticipated benefits of the planned transaction not being realized, changes in general economic conditions particularly in the automobile, computer, information technology, home appliance, industrial and commercial machinery and equipment, and related product markets, shifts in technology or user preferences for particular technologies, and changes in business and regulatory environments. The Nidec Group does not undertake any obligation to update the forward-looking statements contained herein or the reasons why actual results could differ from those projected in the forward-looking statements except as required by law.

Masahiro Nagayasu General Manager Investor Relations +81-75-935-6140

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Master Sommeliers and Italian Producers Clash on Wine Lists

Updated Category News Views 87

Wines Jockeying for New York’s Coveted Lists Alright, picture a stage set up in New York City like an arena. But instead of gladiators, you've got master sommeliers on one side and Italian wine producers on the other, each armed with their own arguments. They're locked in a battle over what it really takes to get a bottle imbedded on a New York City's prestigious wine...

Continue Reading
Chemours Faces Class Action Over Fraud Allegations

Updated Category News Views 206

Chemours and the Aftermarket Mirage When it rains, it pours, and for Chemours, the forecast isn't looking sunny. Investors are gearing up to slap Chemours Company (NYSE: CC) with a securities fraud class action. Why, you ask? Overstatement of aftermarket demand for refrigerants left investors high and dry after stock prices took an 18% nosedive. On August 4, 2026,...

Continue Reading
CapCut's AI Tools Reshape Video Content Creation

Updated Category News Views 63

AI Revolution in Marketing Content: CapCut Takes Lead It's like the old guard of marketing has hitched a ride on a rocket. In 2026, CapCut has stomped into the limelight with Better Business Advice giving them a nod for their prowess in AI-driven content creation. This isn't some passing trend; it's a seismic shift in how businesses craft their messages. CapCut ain't just...

Continue Reading
Hims & Hers Faces Securities Lawsuit Amid Stock Dive

Updated Category News Views 119

Hims & Hers Takes a Hit Right out of the gate, we're seeing Hims & Hers Health, Inc. (NYSE:HIMS) embroiled in a securities class action, thanks to some good old-fashioned alleged corporate shenanigans. It's one of those times where you'd cock an eyebrow and say, "What in the world were they thinking?" The FTC has slapped them with accusations of misleading privacy claims...

Continue Reading
DIRECTV Bags New NHL Deals: Stakes for Sports Fans

Updated Category News Views 177

NHL Fans, Strap in: DIRECTV Expands Its Lineup In a world where keeping up with your favorite team gets tougher each day, DIRECTV just lobbed a puck right into the net with their latest play. They've snagged a multi-year deal with the NHL for the Carolina Hurricanes, Columbus Blue Jackets, Minnesota Wild, and St. Louis Blues networks. It's a game changer, folks. If you...

Continue Reading
Stephen A. Smith Calls for Corporate Support of HBCUs

Updated Category News Views 38

A Stand for Education at the White House Stephen A. Smith stirred the pot with his decision to attend a White House dinner, a move that had tongues wagging across the media landscape. But this time, it wasn't about the usual hustle and bustle of the sports world. Smith had his sights set on the big picture, specifically, the long-term financial stability of Historically...

Continue Reading
York Space Systems Class Action: Deadline Approaches

Updated Category News Views 104

Rapid Deadline: October 30 Looms for York Space Systems You blink, and you might miss the deadline. We’re just a step away from deadline day in the York Space Systems’ class action lawsuit. If you've got skin in this game, time's not on your side. Shareholders, particularly those who hopped on the York Space train via their IPO back in January 2026, are staring down...

Continue Reading
Apalutamide Boosts Outlook for Prostate Cancer Treatment

Updated Category News Views 46

Fresh Findings on High-Risk Prostate Cancer Treatments In an industry that often feels like a game of chess, Johnson & Johnson's recent news unveils another one of their strategic moves with the announcement of breakthrough results from their Phase 3 PROTEUS substudy. Turns out, ERLEADA®, their apalutamide treatment, isn't just another pawn; it's a potential...

Continue Reading
Gentex Shares Tumble Amid Legal Investigation Concerns

Updated Category News Views 10

Gentex's Financial Outlook Takes a Hit Well, here we are again, catching another corporate hiccup. Gentex Corporation, or as ticker hounds know it, NASDAQ:GNTX, just pulled the rug out from its investors by chopping the top off its 2026 revenue guidance. Dropping to a floor it once considered a ceiling, $2.65 billion is now the most optimistic number they're pitching. No...

Continue Reading
Lilly's Sofe-M Shakes Up Ovarian Cancer Treatment

Updated Category News Views 198

Ovarian Cancer Treatment Sees a New Challenger Alright, folks, Eli Lilly (NYSE:LLY) is stepping up with their latest findings in ovarian cancer treatment, and it's got plenty of people in a buzz. They've dropped new data for their investigational drug, Sofetabart mipitecan, or 'Sofe-M' for short, which targets this unrelenting disease with a punch that’s hard to ignore....

Continue Reading

Top 5 Most Recently Viewed Articles

MiMedx Group Q4 Earnings: Impressive Beat Raises Eyebrows

Updated Category News Views 262

What a Turnaround! Numbers don’t lie, right? Well, take a look at MiMedx Group (NASDAQ:MDXG) and you see a company that’s done some real transformation. Their Q4 report came out on February 25, 2026, and it’s hard not to be impressed. They smashed the earnings estimate—by a whopping 40%. That’s no small feat in this market, especially when you look at the EPS...

Continue Reading
Intuitive Machines Sets Financial Results Conference Call Date

Updated Category News Views 132

Intuitive Machines Schedules Conference Call for Financial Results Intuitive Machines, Inc. (Nasdaq: LUNR) has made an important announcement regarding its upcoming financial results. The company is set to release its fourth quarter and full-year financial outcomes, providing an in-depth look at its performance for 2024. This announcement will be made on a specific date...

Continue Reading
OSB Group PLC: Insights into the Latest Block Listing Return

Updated Category News Views 326

Understanding OSB Group PLC's Block Listing Return In the ever-evolving landscape of financial markets, regular disclosures play a pivotal role in maintaining transparency. Here, we delve into the latest block listing return from OSB Group PLC, outlining crucial details in a clear and concise manner. Key Details of the Block Listing Return It's essential for stakeholders...

Continue Reading
Gemini Expands its Offerings with Tokenized U.S. Equities

Updated Category News Views 342

Gemini Launches Tokenized U.S. Equities In an exciting development for European investors, Gemini has expanded its offerings by facilitating the trading of tokenized U.S. equities. This marks a significant shift in providing easier access to international investment opportunities. Initially launched for its user base in Europe, Gemini aims to create a seamless experience...

Continue Reading
Vivian Health Welcomes New CEO Bill Kong for Future Growth

Updated Category News Views 125

Vivian Health's New Era with CEO Bill Kong Vivian Health, a prominent player in the healthcare jobs marketplace, is transitioning into a new chapter under the leadership of Bill Kong, who has been appointed as the CEO. This strategic move follows the remarkable success achieved by Parth Bhakta, co-founder and outgoing CEO, who now assumes the role of Executive Chairman....

Continue Reading